tiprankstipranks
Soleno Therapeutics Inc (SLNO)
NASDAQ:SLNO
US Market

Soleno Therapeutics (SLNO) Ownership - Who Owns Soleno Therapeutics?

Compare
727 Followers

Soleno Therapeutics (SLNO) Ownership Overview

17.69%12.95%0.09%8.42%60.84%
17.69% Insiders
0.09% Other Institutional Investors
8.42% ETFs
60.84% Public Companies and Individual Investors
The ownership structure of Soleno Therapeutics (SLNO) stock is a mix of institutional, retail, and individual investors. Approximately 21.46% of the company’s stock is owned by Institutional Investors, 17.69% is owned by Insiders, and 60.84% is owned by Public Companies and Individual Investors.
The ownership structure of Soleno Therapeutics (SLNO) stock is a mix of institutional, retail, and individual investors. Approximately 13.04% of the company’s stock is owned by Institutional Investors, 17.69% is owned by Insiders, and 8.42% is owned by Public Companies and Individual Investors.

Recent Insider Trading Activity

Date
Name
Activity
Value
Jan 06, 2025
Kristen Yen
Svp, Clinical Operations
xxxxxxxxxxxxx
$222456
Jan 06, 2025
xxxxxxxxxxxxx
$360415
Jan 06, 2025
Patricia C Hirano
Svp, Regulatory Affairs
xxxxxxxxxxxxx
$138692
Jan 06, 2025
Anish Bhatnagar
Ceo,director
xxxxxxxxxxxxx
$965394

Recent Hedge Fund Trading Activity

Date
Firm
Activity
Value
Dec 31, 2024
xxxxxxxxxxxxx
$4045500
Dec 31, 2024
xxxxxxxxxxxxx
$13555211
Dec 31, 2024
xxxxxxxxxxxxx
$67471748

Top Shareholders

Holder
# of Shares
Type
% Holding
Value
6,291,851Insider14.59%309,370,314
3,204,976Institution7.43%157,588,670
1,773,538Institution4.11%87,204,863
1,318,833Institution3.06%64,847,019
1,278,270Institution2.96%62,852,536
1,005,812Institution2.33%49,455,776
764,708Institution1.77%37,600,692
752,362Insider1.74%36,993,640
402,083Institution0.93%19,770,421
335,722Institution0.78%16,507,451

Top Mutual Fund Holders

Holder
# of Shares
Type
% Holding
Value
1,318,833Institution3.06%64,847,019
1,278,270Institution2.96%62,852,536
335,722Institution0.78%16,507,451
314,900Institution0.73%15,483,633
300,000Institution0.70%14,751,000
252,794Institution0.59%12,429,881
237,970Institution0.55%11,700,985
227,111Institution0.53%11,167,048
189,439Institution0.44%9,314,716
172,599Institution0.40%8,486,693

Top ETF Holders

Holder
# of Shares
Type
% Holding
Value
1,128,391Institution2.62%50,721,175
711,688Institution1.65%36,530,945
689,374Institution1.60%33,896,520
411,954Institution0.96%18,517,332
228,109Institution0.53%11,216,120
126,136Institution0.29%6,474,561
121,165Institution0.28%5,446,367
75,920Institution0.18%3,412,604
48,606Institution0.11%2,494,946
28,169Institution0.07%1,385,070

FAQ

Who Owns Soleno Therapeutics Inc (SLNO)?
According to the latest TipRanks data, approximately 0.09% of the company's stock is held by institutional investors, 17.69% is held by insiders, and 60.84% is held by retail investors.
    What percentage of Soleno Therapeutics Inc (SLNO) stock is held by institutional investors?
    According to the latest TipRanks data, approximately 0.09% of Soleno Therapeutics Inc (SLNO) stock is held by institutional investors.
      What percentage of Soleno Therapeutics Inc (SLNO) stock is held by retail investors?
      According to the latest TipRanks data, approximately 60.84% of Soleno Therapeutics Inc (SLNO) stock is held by retail investors.
        Who owns the most shares of Soleno Therapeutics Inc (SLNO)?
        Vivo Opportunity, LLC owns the most shares of Soleno Therapeutics Inc (SLNO).
          What is the significance of the ownership structure for a publicly traded company?
          The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.
            What am I Missing?
            Make informed decisions based on Top Analysts' activity
            Know what industry insiders are buying
            Get actionable alerts from top Wall Street Analysts
            Find out before anyone else which stock is going to shoot up
            Get powerful stock screeners & detailed portfolio analysis